Trxade Group, Inc. Reports Second Quarter 2016 Financial Results Second Quarter Highlights: Second quarter 2016 revenues increased 45% from same period in 2015Number of S2P independent pharmacies continues to expand, now over 5,860Company has launched Gabapentin...

CORRECTING and REPLACING -- Trxade Group Achieves Record First Quarter 2016 Financial Results Driven by a 165% Increase in Revenues Over First Quarter 2015 TAMPA, Fla., April 21, 2016 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by Trxade Group, Inc. (OTCQB: TRXD) we are advised by the company that the third bullet...

Trxade Group Achieves Record First Quarter 2016 Financial Results Driven by a 165% Increase in Revenues Over First Quarter 2015 First Quarter Highlights:Company achieves record revenues of $1.8 million in quarter ending March 31, 2016, an increase of 165% over $696,000 in quarter ending March 31, 2015Gross profit increased to...

UPDATE -- Trxade Group, Inc. Launches HCTZ (Hydrochlorothiazide) to Treat Fluid Edema TAMPA, Fla., Feb. 09, 2016 (GLOBE NEWSWIRE) -- Trxade Group, Inc. (OTCQB:TRXD), a web-based pharmaceutical marketplace engaged in promoting and enabling trade among independent pharmacies and large...

Trxade Group, Inc. Launches HCTZ (Hydrochlorothiazide) to Treat Fluid Edema TAMPA, Fla., Feb. 09, 2016 (GLOBE NEWSWIRE) -- Trxade Group, Inc. (OTCQB:TRXD), a web-based pharmaceutical marketplace engaged in promoting and enabling trade among independent pharmacies and large...